EndoStim officially spikes $35m IPO
EndoStim today officially spiked an initial public offering it hoped would raise $35 million for its neurostimulation device for gastroesophageal reflux disease.
EndoStim, which had planned to put $10 million of the IPO’s proceeds into clinical studies and another $14 million to commercialize the system, tabled the offering in October 2014. Today the company filed a formal withdrawal request with the U.S. Securities & Exchange Commission, citing “market conditions.”
EndoStim is operating from a small headquarters in St. Louis where it employs 13 people, including CEO Bevil Hogg, who took Stereotaxis (N...
Source: Mass Device - December 9, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Initial Public Offering (IPO) Funding Roundup EndoStim Source Type: news
Rapid UHPLC Method Development for Omeprazole Analysis
The aim of this study was to apply quality by design principles to build in a more scientific and risk-based multifactorial strategy in the development of an ultra high-pressure liquid chromatography (UHPLC) method for omeprazole and its related impu… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 2, 2015 Category: Pharmaceuticals Source Type: news
Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT)
Source: NYT - October 15, 2015 Category: Nutrition Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news
Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT Health)
Source: NYT Health - October 15, 2015 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news
Aurobindo Pharma gets USFDA nod to market ulcer drug
The company's approved abbreviated new drug application (ANDA) is a generic version of AstraZeneca Pharmaceuticals' Prilosec capsules, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2015 Category: Pharmaceuticals Source Type: news
Fast Relief For Heartburn
When heartburn hits, you need a fast and reliable way of dealing with the pain.
But before you take another antacid, or prescription like Nexium, Prilosec, or Prevacid, there’s something I want to share with you.
Heartburn drugs actually make your condition worse over time. And there’s new evidence they boost your risk of heart attack by up to 20%.
I know it’s frustrating to hear another prescription drug is doing terrible things to your body.
But today, I’ll show you a few options that will shut down heartburn almost immediately.
These options are safe, affordable, and easy to use.
Let m...
Source: Al Sears, MD Natural Remedies - July 17, 2015 Category: Complementary Medicine Authors: Andrew Britton Tags: Anti-Aging Source Type: news
omeprazole, omeprazole/sodium bicarbonate, Prilosec, Zegerid, Prilosec OTC, Zegerid OTC
Title: omeprazole, omeprazole/sodium bicarbonate, Prilosec, Zegerid, Prilosec OTC, Zegerid OTCCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/1/2015 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 1, 2015 Category: Nutrition Source Type: news
Data Dive Suggests Link Between Heartburn Drugs And Heart Attacks
The drugs are proton-pump inhibitors, including Prilosec, Nexium and Prevacid. But the study doesn't show cause and effect. Other factors — diet, drink or tobacco — may play a role.» E-Mail This (Source: NPR Health and Science)
Source: NPR Health and Science - June 11, 2015 Category: Consumer Health News Authors: Richard Harris Source Type: news
Common heartburn drugs could raise risk of heart attacks
Millions of people take drugs known as proton pump inhibitors (PPIs) to treat heartburn and acid reflux. Popular brands include Prilosec, Prevacid and Nexium. But now a new study raises concern that they may increase the risk of heart attacks. Brian Webb reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 11, 2015 Category: Consumer Health News Source Type: news
Well: Heartburn Drugs Linked to Heart Attacks
Drugs like Prilosec and Prevacid may increase the risk for heart attack. (Source: NYT)
Source: NYT - June 10, 2015 Category: American Health Authors: NICHOLAS BAKALAR Tags: Heart Drugs (Pharmaceuticals) Body Featured Source Type: news
Well: Heartburn Drugs Linked to Heart Attacks
Drugs like Prilosec and Prevacid may increase the risk for heart attack. (Source: NYT Health)
Source: NYT Health - June 10, 2015 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Heart Drugs (Pharmaceuticals) Body Featured Source Type: news
Indigestion drugs like omeprazole 'increase heart attack risk'
Researchers at Stanford and Houston Methodist universities found those who take proton pump inhibitor, or PPI, drugs are around 20 per cent more likely to suffer a heart attack than others. (Source: the Mail online | Health)
Source: the Mail online | Health - June 10, 2015 Category: Consumer Health News Source Type: news
